Brokerages Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Price Target at $15.15

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has received an average recommendation of “Reduce” from the fourteen research firms that are covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $14.8333.

XRAY has been the topic of a number of recent research reports. Barclays initiated coverage on shares of DENTSPLY SIRONA in a report on Monday, December 8th. They set an “underweight” rating and a $12.00 price target on the stock. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Mizuho boosted their price target on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a research report on Tuesday. JPMorgan Chase & Co. lowered their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, November 7th. Finally, Evercore ISI reduced their target price on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a report on Wednesday, October 8th.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $13.00 on Tuesday. DENTSPLY SIRONA has a fifty-two week low of $9.85 and a fifty-two week high of $20.59. The stock’s 50-day moving average is $11.48 and its two-hundred day moving average is $12.94. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The firm has a market cap of $2.59 billion, a P/E ratio of -2.94, a PEG ratio of 0.99 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.08). DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The firm had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.33 million. During the same period in the previous year, the firm posted $0.50 EPS. The company’s quarterly revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.9%. The ex-dividend date was Friday, December 26th. DENTSPLY SIRONA’s payout ratio is presently -14.48%.

Insider Activity

In related news, Director Gregory T. Lucier sold 82,200 shares of the firm’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $11.14, for a total value of $915,708.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.50% of the company’s stock.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds have recently bought and sold shares of the company. Sound Income Strategies LLC increased its stake in shares of DENTSPLY SIRONA by 32.3% in the fourth quarter. Sound Income Strategies LLC now owns 611,308 shares of the medical instruments supplier’s stock worth $7,464,000 after purchasing an additional 149,384 shares during the period. BFI Infinity Ltd. grew its holdings in DENTSPLY SIRONA by 200.0% in the 4th quarter. BFI Infinity Ltd. now owns 21,111 shares of the medical instruments supplier’s stock valued at $241,000 after buying an additional 42,222 shares during the last quarter. SG Americas Securities LLC bought a new position in DENTSPLY SIRONA in the 4th quarter worth approximately $1,064,000. Allworth Financial LP increased its position in DENTSPLY SIRONA by 66.6% in the 3rd quarter. Allworth Financial LP now owns 10,323 shares of the medical instruments supplier’s stock worth $131,000 after buying an additional 4,127 shares during the period. Finally, Caerus Investment Advisors LLC acquired a new position in shares of DENTSPLY SIRONA during the third quarter worth approximately $153,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.